Search Results - Erik Sjögren

Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models by David Dahlgren, Erik Sjögren, Hans Lennernäs

Connect to this object online.

A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children by Erik Sjögren, Joel Tarning, Karen I. Barnes, E. Niclas Jonsson

Connect to this object online.

Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug-drug interaction by Luna Prieto Garcia, Anna Lundahl, Christine Ahlström, Anna Vildhede, Hans Lennernäs, Erik Sjögren

Connect to this object online.

Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins by Luna Prieto Garcia, Anna Vildhede, Pär Nordell, Christine Ahlström, Ahmed B. Montaser, Tetsuya Terasaki, Hans Lennernäs, Erik Sjögren

Connect to this object online.

PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space by Michael E. Cloesmeijer, Erik Sjögren, Sjoerd F. Koopman, Peter. J. Lenting, Marjon H. Cnossen, Ron A. A. Mathôt, the OPTI‐CLOT study group and SYMPHONY consortium

Connect to this object online.

Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences by Jörg Lippert, Rolf Burghaus, Andrea Edginton, Sebastian Frechen, Mats Karlsson, Andreas Kovar, Thorsten Lehr, Peter Milligan, Valerie Nock, Sergej Ramusovic, Matthew Riggs, Stephan Schaller, Jan Schlender, Stephan Schmidt, Michaël Sevestre, Erik Sjögren, Juri Solodenko, Alexander Staab, Donato Teutonico

Connect to this object online.